CAMP and psoriasis: In addition, it was reported that LL-37 might activate monocytes (P2 × 7 receptor), leading to inflammasome activation and IL-1β production [5,62], whereas DNA bound by LL-37 did not enhance Il-1β secretion in psoriasis [63].